James Haddad, MD
Gastroenterology · McKinney, TXNPI 1700126026
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.6% of it on its own, with 24 other manufacturers making up the rest.
Across 161 payments — averaging $67.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- AbbVie$732
- Johnson & Johnson$391
- Conmed Corporation$332
- Janssen Scientific Affairs, LLC$239
- Lilly USA, LLC$175
- plus $1K from 19 others
What the payments were for
- Travel & lodging$4,43041%
- Food & beverage$6,39459%
- Education$310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Resolution 360 Clip$1,930
- Apollo ESG NXT System$886
- Tremfya$239
- CONMED EUS$189
- GENERAL - METAL STENTS - G.I.$148
- CRE PRO$148
- GENERAL - THERAPIES$144
- CONMED GENERATORS$143
- AXIOS$137
- NEXPOWDER$125
- STELARA$122
- REMICADE$122
- Skyrizi$120
- SPYGLASS$119
- OverStitch Endoscopic Suturing System$109
- Mavyret$106
How this compares
$10,855 in reported general payments places this provider in the 80th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 11 | $263 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in McKinney
- Rajesh PutchaMcKinney$210K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Nadege GunnWaco$933K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.